Close
ACHEMA MIDDLE EAST 2026

Juno Closes $134M Series B Round

Juno Therapeutics, Inc., a biotechnology company focused on bringing forward novel immunotherapies for cancer, today announced that it has closed its Series B round...

AcelRx Pharmaceuticals to Hold Second Quarter Financial Results Conference Call and Webcast

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain,...

Synergy Pharmaceuticals Reports Second Quarter and First Half 2014 Financial Results

Synergy Pharmaceuticals Inc., today reported its financial results and business update for the three and six months ended June 30, 2014.   Key Development...

Rock Creek Pharmaceuticals Reports Second Quarter and Announces Clinical Update

Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI), a drug development company focused on chronic inflammatory disease and neurologic disorders, announced today that it filed with...

PDA Opens Quality Culture Survey

The Parenteral Drug Association (PDA) today launched one of two surveys on Quality Culture Metrics as part of its continuing program to evaluate quality...

CannaVest Reports Second Quarter 2014 Financial Results

CannaVest Corp. - ("CannaVest" or the "Company") is reporting financial results for the quarter ending June 30, 2014. Logo - http://photos.prnewswire.com/prnh/20140403/LA98016LOGO During the quarter,...

Morphogenesis announces USDA-sanctioned clinical trial for promising equine cancer vaccine

Morphogenesis Inc., the biotechnology firm developing ImmuneFx™, a cancer vaccine that has improved the longevity and quality of life for dogs, cats and horses,...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...